Updated Jul 16, 2026
Loy Spike has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
Loy Spike is identified in SEC filings as a Director of MoonLake Immunotherapeutics as of June 18, 2026. Public biographical information about Loy Spike beyond this SEC reference is not readily available in widely known sources. Based on the provided SEC context, this appears to be a corporate governance role rather than a widely public figure.
| Role | Director |
|---|---|
| Notability | 15/100 |
Loy Spike is identified in SEC filings as a Director of MoonLake Immunotherapeutics as of June 18, 2026. Public biographical information about Loy Spike beyond this SEC reference is not readily available in widely known sources. Based on the provided SEC context, this appears to be a corporate governance role rather than a widely public figure.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Loy Spike profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.